Skip to main content

Advertisement

SpringerLink
Log in

Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a scoping review

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

We undertook a scoping review of the literature to synthesize what is known about lymphoma survivorship and develop a comprehensive set of lymphoma-specific survivorship recommendations.

Methods

We searched the peer-reviewed literature from January 1995 to April 2022, focused on topics relevant to survivorship care in patients ≥ 18 years of age, treated curatively for non-Hodgkin’s and Hodgkin’s lymphoma, and in remission for at least 2 years.

Results

We retained 92 articles; themes included late effects of treatment (53.3%, 49/92), particularly fatigue and sleep disturbances, and fertility, as well as psychosocial considerations of survivors (27.2%; 25/92), screening for secondary malignancies (22.8%; 21/92), outcomes of interventions to improve survivorship care (10.9%; 10/92), and best practices and elements for survivorship plans (8.7%; 8/92). While there were published guidelines for screening for recurrence and secondary malignancies, despite the considerable number of articles on the psychosocial aspects of survivorship care, there remains limited guidance on screening frequency and management strategies for anxiety and depression, sleep disturbances, and treatment-related fatigue within the lymphoma population.

Conclusion

We have developed a comprehensive set of lymphoma-survivorship recommendations; however, work is needed to adapt them to local healthcare contexts.

Implications for survivors

While there is a focus in the literature on the long-term psychosocial impacts of cancer and its treatment on lymphoma survivors, there remains no concrete recommendations on effective screening and management of detriments to quality of life such as anxiety, depression, fatigue, and distress, and availability of local resources vary widely.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Not applicable.

References

  1. World Cancer Research Fund International. Worldwide cancer data. 2022. https://www.wcrf.org/cancer-trends/worldwide-cancer-data/. Accessed 10 August 2023.

  2. Cancer Research UK. Hodgkin lymphoma. 2022. https://tinyurl.com/yc78czj5 . Accessed 5 September 2023.

  3. Boyne DJ, Mickle AT, Brenner DR, Friedenreich CM, Cheung WY, Tang KL, Wilson TA, Lorenzetti DL, James MT, Ronksley PE, Rabi DM. Long-term risk of cardiovascular mortality in lymphoma survivors: a systematic review and meta-analysis. Cancer Med. 2018;7(9):4801–13.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Williams AM, Zent CS, Janelsins MC. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. Br J Haematol. 2016;174(6):835–46.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Troy JD, Locke SC, Samsa GP, Feliciano J, Richhariya A, LeBlanc TW. Patient-reported distress in Hodgkin lymphoma across the survivorship continuum. Support Care Cancer. 2019;27(7):2453–62.

    Article  PubMed  Google Scholar 

  6. Husson O, Prins JB, Kaal SE, Oerlemans S, Stevens WB, Zebrack B, van der Graaf WT, van de Poll-Franse LV. Adolescent and young adult (AYA) lymphoma survivors report lower health-related quality of life compared to a normative population: results from the PROFILES registry. Acta Oncol. 2017;56(2):288–94.

    Article  PubMed  Google Scholar 

  7. Berkley A. Support for adult survivors of lymphoma: a literature review. Br J Nurs. 2022;31(17):S12–6.

    Article  PubMed  Google Scholar 

  8. Heveran L, Andrewes T. Nursing measures to support the needs of haematological cancer survivors post-treatment: a literature review. Br J Nurs. 2020;29(3):S18–24.

    Article  PubMed  Google Scholar 

  9. Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition: an American Society of Clinical Oncology and Institute of Medicine symposium. Washington, DC: The National Academies Press; 2006.

    Google Scholar 

  10. MD Anderson Cancer Centre. Cancer survivorship algorithms. 2023. https://www.mdanderson.org/for-physicians/clinical-tools-resources/clinical-practice-algorithms/survivorship-algorithms.html. Accessed 15 September 2022.

  11. National Comprehensive Cancer Network. Survivorship care for cancer-related late or long-term effects. 2020. https://www.nccn.org/patients/guidelines/content/PDF/survivorship-crl-patient.pdf. Accessed 13 September 2022.

  12. American Society of Clinical Oncology. Guidelines on survivorship care. 2023. https://old-prod.asco.org/news-initiatives/current-initiatives/cancer-care-initiatives/survivorship-compendium/guidelines. Accessed 23 September 2022.

  13. American Cancer Society. Key statistics for non-Hodgkin’s lymphoma. 2023. https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/key-statistics.html. Accessed 23 September 2022.

  14. Zahid U, Akbar F, Amaraneni A, Husnain M, Chan O, Riaz IB, McBride A, Iftikhar A, Anwer F. A review of autologous stem cell transplantation in lymphoma. Curr Hematol Malig Rep. 2017;12(3):217–26.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.

    Article  PubMed  Google Scholar 

  16. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579–86.

    Article  PubMed  Google Scholar 

  17. Oeffinger KC, Hudson MM, Mertens AC, Smith SM, Mitby PA, Eshelman-Kent DA, Ford JS, Jones JK, Kamani S, Robison LL. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer. 2011;56(5):818–24.

    Article  PubMed  Google Scholar 

  18. Abu Sabaa A, Mörth C, Hasselblom S, Hedström G, Flogegård M, Stern M, Andersson PO, Glimelius I, Enblad G. Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study. Br J Haematol. 2021;193(5):906–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Milligan DW, Ruiz De Elvira MC, Kolb HJ, Goldstone AH, Meloni G, Rohatiner AZ, Colombat P, Schmitz N. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol. 1999;106(4):1020–6.

    Article  PubMed  CAS  Google Scholar 

  20. Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, Cortelazzo S, Zoli V, Corradini P, Carobbio A, Mulé A, Bosa M, Barbui A, Di Nicola M, Sorio M, Caracciolo D, Gianni AM, Rambaldi A. Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. J Clin Oncol. 2011;29(7):814–24.

    Article  PubMed  CAS  Google Scholar 

  21. Seshadri T, Pintilie M, Kuruvilla J, Keating A, Tsang R, Zadeh S, Crump M. Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50(3):380–6.

    Article  PubMed  Google Scholar 

  22. Scholz M, Engert A, Franklin J, Josting A, Diehl V, Hasenclever D, Loeffler M. Impact of first- and second-line treatment for Hodgkin’s lymphoma on the incidence of AML/MDS and NHL–experience of the German Hodgkin’s Lymphoma Study Group analyzed by a parametric model of carcinogenesis. Ann Oncol. 2011;22(3):681–8.

    Article  PubMed  CAS  Google Scholar 

  23. Grunfeld E, Moineddin R, Gunraj N, Del Giudice ME, Hodgson DC, Kwon JS, Elit L. Cancer screening practices of cancer survivors: population-based, longitudinal study. Can Fam Physician. 2012;58(9):980–6.

    PubMed  PubMed Central  Google Scholar 

  24. Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S. Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis. Ann Oncol. 2011;22(8):1845–58.

    Article  PubMed  CAS  Google Scholar 

  25. Lorenzo Bermejo J, Pukkala E, Johannesen TB, Sundquist J, Hemminki K. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden. Br J Haematol. 2014;164(5):675–83.

    Article  PubMed  Google Scholar 

  26. Fleury I, Chevret S, Pfreundschuh M, Salles G, Coiffier B, van Oers MH, Gisselbrecht C, Zucca E, Herold M, Ghielmini M, Thieblemont C. Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis. Ann Oncol. 2016;27(3):390–7.

    Article  PubMed  CAS  Google Scholar 

  27. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister TA, Radford JA, Rohatiner AZ, Linch DC. Second cancer risk after chemotherapy for Hodgkin’s lymphoma: a collaborative British cohort study. J Clin Oncol. 2011;29(31):4096–104.

    Article  PubMed  CAS  Google Scholar 

  28. Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, Meijer GA, de Boer JP, van Leeuwen FE, van Leerdam ME. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors. Cancer. 2019;125(6):990–9.

    Article  PubMed  CAS  Google Scholar 

  29. van Eggermond AM, Schaapveld M, Janus CP, de Boer JP, Krol AD, Zijlstra JM, van der Maazen RW, Kremer LC, van Leerdam ME, Louwman MW, Visser O, De Bruin ML, Aleman BM, van Leeuwen FE. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. Br J Cancer. 2017;117(3):306–14.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Gini A, Meester RGS, Keshavarz H, Oeffinger KC, Ahmed S, Hodgson DC, Lansdorp-Vogelaar I. Cost-effectiveness of colonoscopy-based colorectal cancer screening in childhood cancer survivors. J Natl Cancer Inst. 2019;111(11):1161–9.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ykema B, Rigter L, Spaander M, Moons L, Bisseling T, Aleman B, de Boer JP, Lugtenburg P, Janus C, Petersen E, Roesink J, Raemaekers J, van der Maazen R, Lansdorp-Vogelaar I, Gini A, Verbeek W, Lemmens M, Meijer G, van Leeuwen F, Snaebjornsson P, Carvalho B, van Leerdam M. Diagnostic accuracy of stool tests for colorectal cancer surveillance in Hodgkin lymphoma survivors. J Clin Med. 2020;9(1):190.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Ibrahim EM, Abouelkhair KM, Kazkaz GA, Elmasri OA, Al-Foheidi M. Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis. BMC Cancer. 2012;12:197.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin’s lymphoma: a multi-institutional, matched cohort study. J Clin Oncol. 2011;29(18):2466–73.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sanna G, Lorizzo K, Rotmensz N, Bagnardi V, Cinieri S, Colleoni M, Nolè F, Goldhirsch A. Breast cancer in Hodgkin’s disease and non-Hodgkin’s lymphoma survivors. Ann Oncol. 2007;18(2):288–92.

    Article  PubMed  CAS  Google Scholar 

  35. Furzer J, Tessier L, Hodgson D, Cotton C, Nathan PC, Gupta S, Pechlivanoglou P. Cost-utility of early breast cancer surveillance in survivors of thoracic radiation-treated adolescent Hodgkin lymphoma. J Natl Cancer Inst. 2020;112(1):63–70.

    Article  PubMed  Google Scholar 

  36. Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013;31(18):2282–8.

    Article  PubMed  Google Scholar 

  37. Hodgson DC, Cotton C, Crystal P, Nathan PC. Impact of early breast cancer screening on mortality among young survivors of childhood Hodgkin’s lymphoma. J Natl Cancer Inst. 2016;108(7). https://doi.org/10.1093/jnci/djw010.

  38. Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, Bayer AM, Elmasri OA. Increased risk of second lung cancer in Hodgkin’s lymphoma survivors: a meta-analysis. Lung. 2013;191(1):117–34.

    Article  PubMed  CAS  Google Scholar 

  39. Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys. 2014;90(2):344–53.

    Article  PubMed  Google Scholar 

  40. Broadbent R, Gorman L, Armitage CJ, Radford J, Linton K. The perspectives of survivors of Hodgkin lymphoma on lung cancer screening: a qualitative study. Health Expect. 2022;25(1):116–24.

    Article  PubMed  Google Scholar 

  41. Nord C, Mykletun A, Thorsen L, Bjøro T, Fosså SD. Self-reported health and use of health care services in long-term cancer survivors. Int J Cancer. 2005;114(2):307–16.

    Article  PubMed  CAS  Google Scholar 

  42. Moser EC, Noordijk EM, Carde P, Tirelli U, Baars JW, Thomas J, Bron D, Meerwaldt JH, van Glabbeke M, Raemaekers JM, Kluin-Nelemans HC. Late non-neoplastic events in patients with aggressive non-Hodgkin’s lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. Clin Lymphoma Myeloma. 2005;6(2):122–30.

    Article  PubMed  Google Scholar 

  43. Immanuel A, Hunt J, McCarthy H, van Teijlingen E, Sheppard ZA. Quality of life in survivors of adult haematological malignancy. Eur J Cancer Care (Engl). 2019;28(4):e13067.

    Article  PubMed  Google Scholar 

  44. Kreissl S, Müller H, Goergen H, Meissner J, Topp M, Sökler M, Markova J, Bernhard J, Greil R, von Tresckow B, Behringer K, Rüffer JU, Flechtner HH, Möstl M, Fuchs M, Engert A, Diehl V, Borchmann P. Health-related quality of life in patients with Hodgkin lymphoma: a longitudinal analysis of the German Hodgkin Study Group. J Clin Oncol. 2020;38(25):2839–48.

    Article  PubMed  Google Scholar 

  45. Majhail NS, Ness KK, Burns LJ, Sun CL, Carter A, Francisco L, Forman SJ, Bhatia S, Baker KS. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13(10):1153–9.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Jung HS, Myung SK, Kim BS, Seo HG. Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract. 2012;95(2):275–82.

    Article  PubMed  Google Scholar 

  47. Trachtenberg E, Mashiach T, Ben Hayun R, Tadmor T, Fisher T, Aharon-Peretz J, Dann EJ. Cognitive impairment in Hodgkin lymphoma survivors. Br J Haematol. 2018;182(5):670–8.

    Article  PubMed  Google Scholar 

  48. Heutte N, Flechtner HH, Mounier N, Mellink WA, Meerwaldt JH, Eghbali H, van’t Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RW, Smit WG, Brice P, van MarwijkKooy M, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomsic R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers GJ, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Fermé C, Henry-Amar M, EORTC-GELA H8 Trial Group. Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol. 2009;10(12):1160–70.

    Article  PubMed  Google Scholar 

  49. Rüffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, Diehl V, German Hodgkin Lymphoma Study Group. Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer. 2003;39(15):2179–86.

    Article  PubMed  Google Scholar 

  50. Kreissl S, Mueller H, Goergen H, Mayer A, Brillant C, Behringer K, Halbsguth TV, Hitz F, Soekler M, Shonukan O, Rueffer JU, Flechtner HH, Fuchs M, Diehl V, Engert A, Borchmann P, German Hodgkin Study Group. Cancer-related fatigue in patients with and survivors of Hodgkin’s lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol. 2016;17(10):1453–62.

    Article  PubMed  Google Scholar 

  51. Busson R, van der Kaaij M, Mounier N, Aleman BMP, Thiéblemont C, Stamatoullas A, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Kluin-Nelemans HC, Henry-Amar M. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study. Health Qual Life Outcomes. 2019;17(1):115.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Starreveld DEJ, Habers GEA, Valdimarsdottir HB, Kessels R, Daniëls LA, van Leeuwen FE, Bleiker EMA. Cancer-related fatigue in relation to chronotype and sleep quality in (non-)Hodgkin lymphoma survivors. J Biol Rhythms. 2021;36(1):71–83.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Stadtbaeumer N, Müller H, Goergen H, Kreissl S, Borchmann P, Mayer A. The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivors. Health Psychol. 2020;39(10):905–11.

    Article  PubMed  Google Scholar 

  54. Hathiramani S, Pettengell R, Moir H, Younis A. Relaxation versus exercise for improved quality of life in lymphoma survivors-a randomised controlled trial. J Cancer Surviv. 2021;15(3):470–80.

    Article  PubMed  Google Scholar 

  55. Liu L, He X, Feng L. Exercise on quality of life and cancer-related fatigue for lymphoma survivors: a systematic review and meta-analysis. Support Care Cancer. 2019;27(11):4069–82.

    Article  PubMed  Google Scholar 

  56. Fauske L, Bruland ØS, Dahl AA, Myklebostad A, Reme SE. Does the lightning process training programme reduce chronic fatigue in adolescent and young adult cancer survivors? A mixed-methods pilot study. Cancers (Basel). 2021;13(16):4076.

    Article  PubMed  Google Scholar 

  57. Starreveld DEJ, Daniels LA, Kieffer JM, Valdimarsdottir HB, de Geus J, Lanfermeijer M, van Someren EJW, Habers GEA, Bosch JA, Janus CPM, van Spronsen DJ, de Weijer RJ, Marijt EWA, de Jongh E, Zijlstra JM, Böhmer LH, Houmes M, Kersten MJ, Korse CM, van Rossum HH, Redd WH, Lutgendorf SK, Ancoli-Israel S, van Leeuwen FE, Bleiker EMA. Light therapy for cancer-related fatigue in (non-)Hodgkin lymphoma survivors: results of a randomized controlled trial. Cancers (Basel). 2021;13(19):4948.

    Article  PubMed  Google Scholar 

  58. La Carpia D, Liperoti R, Guglielmo M, Di Capua B, Devizzi LF, Matteucci P, Farina L, Fusco D, Colloca G, Di Pede P, Ferrara ML, Hohaus S, Bernabei R, Ripamonti CI. Cognitive decline in older long-term survivors from non-Hodgkin lymphoma: a multicenter cross-sectional study. J Geriatr Oncol. 2020;11(5):790–5.

    Article  PubMed  Google Scholar 

  59. Seland M, Smeland KB, Bjøro T, Falk RS, Fosså SD, Gjesdal CG, Godang K, Holte H, Svartberg J, Syversen U, Bollerslev J, Kiserud CE. Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation. Acta Oncol. 2017;56(4):590–8.

    Article  PubMed  Google Scholar 

  60. Myrehaug S, Pintilie M, Tsang R, Mackenzie R, Crump M, Chen Z, Sun A, Hodgson DC. Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma. 2008;49(8):1486–93.

    Article  PubMed  CAS  Google Scholar 

  61. Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MA, Ramadan S, Meulemans B, Henry-Amar M, Aleman BM, Raemaekers J, Meijnders P, Moser EC, Kluin-Nelemans HC, Feugier P, Casasnovas O, Fortpied C, Specht L, European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group. Cardiovascular disease after treatment for Hodgkin’s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol. 2015;2(11):e492-502.

    Article  PubMed  Google Scholar 

  62. Nolan MT, Russell DJ, Marwick TH. Long-term risk of heart failure and myocardial dysfunction after thoracic radiotherapy: a systematic review. Can J Cardiol. 2016;32(7):908–20.

    Article  PubMed  Google Scholar 

  63. Murbraech K, Holte E, Broch K, Smeland KB, Holte H, Rösner A, Lund MB, Dalen H, Kiserud C, Aakhus S. Impaired right ventricular function in long-term lymphoma survivors. J Am Soc Echocardiogr. 2016;29(6):528–36.

    Article  PubMed  Google Scholar 

  64. Stone CR, Mickle AT, Boyne DJ, Mohamed A, Rabi DM, Brenner DR, Friedenreich CM. Treatment for lymphoma and late cardiovascular disease risk: a systematic review and meta-analysis. Health Sci Rep. 2019;2(10):e135.

    Article  PubMed  PubMed Central  Google Scholar 

  65. De Bruin ML, Dorresteijn LD, van’t Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101(13):928–37.

    Article  PubMed  Google Scholar 

  66. Rugbjerg K, Mellemkjaer L, Boice JD, Køber L, Ewertz M, Olsen JH. Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943–2009. J Natl Cancer Inst. 2014;106(6):dju110.

    Article  PubMed  Google Scholar 

  67. Jurczak W, Szmit S, Sobociński M, Machaczka M, Drozd-Sokołowska J, Joks M, Dzietczenia J, Wróbel T, Kumiega B, Zaucha JM, Knopińska-Posłuszny W, Spychałowicz W, Prochwicz A, Drohomirecka A, Skotnicki AB. Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study. Int J Cardiol. 2013;168(6):5212–7.

    Article  PubMed  Google Scholar 

  68. Avilés A, Neri N, Nambo JM, Huerta-Guzman J, Talavera A, Cleto S. Late cardiac toxicity secondary to treatment in Hodgkin’s disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy. Leuk Lymphoma. 2005;46(7):1023–8.

    Article  PubMed  Google Scholar 

  69. Behringer K, Thielen I, Mueller H, Goergen H, Eibl AD, Rosenbrock J, Halbsguth T, Eichenauer DA, Fuchs M, Reiners KS, Renno JH, van der Ven K, Kuehr M, von Wolff M, Diehl V, Engert A, Borchmann P. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Ann Oncol. 2012;23(7):1818–25.

    Article  PubMed  CAS  Google Scholar 

  70. Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, Wessels C, Wiehlpütz M, Rosenbrock J, Halbsguth T, Reiners KS, Schober T, Renno JH, von Wolff M, van der Ven K, Kuehr M, Fuchs M, Diehl V, Engert A, Borchmann P. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31(2):231–9.

    Article  PubMed  CAS  Google Scholar 

  71. van der Kaaij MA, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Eghbali H, Brice P, Smit WG, Sebban C, Doorduijn JK, Roesink JM, Gaillard I, Coiffier B, Lybeert ML, Casasnovas O, André M, Raemaekers JM, Henry-Amar M, Kluin-Nelemans JC, European Organisation for Research and Treatment of Cancer Lymphoma Group and the Grouped’Étude des Lymphomes de l’Adulte. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod. 2014;29(3):525–33.

    Article  PubMed  Google Scholar 

  72. van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, Van Hoof A, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC. Premature ovarian failure and fertility in long-term survivors of Hodgkin’s lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d’Etude des Lymphomes de l’Adulte Cohort Study. J Clin Oncol. 2012;30(3):291–9.

    Article  PubMed  Google Scholar 

  73. van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, Allgeier A, Meulemans B, Dubois B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Doorduijn JK, Sebban C, Smit WG, Bologna S, Roesink JM, Ong F, André MP, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol. 2012;30(31):3854–63.

    Article  PubMed  Google Scholar 

  74. Falorio S, Biasoli I, Luminari S, Quintana G, Musso M, Dell’olio M, Specchia MR, di Renzo N, Cesaretti M, Buda G, Vallisa D, Mannina D, Andriani A, Chiattone CS, Delamain MT, de Souza CA, Spector N, Angrilli F, Federico M. Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions. Hematol Oncol. 2013;31(2):72–8.

    Article  PubMed  Google Scholar 

  75. Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016;34(22):2568–74.

    Article  PubMed  CAS  Google Scholar 

  76. Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology. 2007;12(2):141–7.

    Article  PubMed  Google Scholar 

  77. Busnelli A, Vitagliano A, Mensi L, Acerboni S, Bulfoni A, Filippi F, Somigliana E. Fertility in female cancer survivors: a systematic review and meta-analysis. Reprod Biomed Online. 2020;41(1):96–112.

    Article  PubMed  Google Scholar 

  78. Anderson C, Engel SM, Mersereau JE, Black KZ, Wood WA, Anders CK, Nichols HB. Birth outcomes among adolescent and young adult cancer survivors. JAMA Oncol. 2017;3(8):1078–84.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK, Jennings DM, Karakantza M, Al-Ismail S, Collins GP, McConnell S, Langton C, Salek S. Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study. Ther Adv Hematol. 2020;11:2040620720955002.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kuba K, Esser P, Mehnert A, Hinz A, Johansen C, Lordick F, Götze H. Risk for depression and anxiety in long-term survivors of hematologic cancer. Health Psychol. 2019;38(3):187–95.

    Article  PubMed  Google Scholar 

  81. Cunningham C, Wakim P, Hendricks J, Cassidy Q, Telgen E, BrintzenhofeSzoc K. Influence of psychosocial distress on traumatic stress symptoms among oncology patients in clinical trials. J Psychosocial Oncol Res Pract. 2020;2(2):e21.

    Google Scholar 

  82. Noonan D, LeBlanc M, Conley C, Benecha H, Leak-Bryant A, Peter K, Zimmerman S, Mayer D, Smith S. Quality of life and impact of cancer: differences in rural and nonrural non-Hodgkin’s lymphoma survivors. J Rural Health. 2020;36(4):536–42.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Vallance JK, Courneya KS, Jones LW, Reiman T. Differences in quality of life between non-Hodgkin’s lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology. 2005;14(11):979–91.

    Article  PubMed  Google Scholar 

  84. Lekdamrongkul P, Pongthavornkamol K, Molassiotis A, Sriyuktasuth A, Siritanaratkul N, Chansatitporn N. Exploring health-related quality of life among non-Hodgkin’s lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand. Support Care Cancer. 2021;29(11):6511–22.

    Article  PubMed  Google Scholar 

  85. Séguin Leclair C, Lebel S, Westmaas JL. The relationship between fear of cancer recurrence and health behaviors: a nationwide longitudinal study of cancer survivors. Health Psychol. 2019;38(7):596–605.

    Article  PubMed  Google Scholar 

  86. Latella LE, Rogers M, Leventhal H, Parker PA, Horwitz S, Matasar MJ, Bylund CL, Kissane DW, Franco K, Banerjee SC. Fear of cancer recurrence in lymphoma survivors: a descriptive study. J Psychosoc Oncol. 2020;38(3):251–71.

    Article  PubMed  Google Scholar 

  87. Parker PA, Banerjee SC, Matasar MJ, Bylund CL, Schofield E, Li Y, Jacobsen PB, Astrow AB, Leventhal H, Horwitz S, Kissane D. Cancer worry and empathy moderate the effect of a survivorship-focused intervention on quality of life. Psychooncology. 2020;29(6):1012–8.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Vargas-Román K, Díaz-Rodríguez CL, Cañadas-De la Fuente GA, Gómez-Urquiza JL, Ariza T, De la Fuente-Solana EI. Anxiety prevalence in lymphoma a systematic review and meta-analysis. Health Psychol. 2020;39(7):580–8.

    Article  PubMed  Google Scholar 

  89. Rottenberg Y, de Boer AGEM. Risk for unemployment at 10 years following cancer diagnosis among very long-term survivors: a population based study. J Cancer Surviv. 2020;14(2):151–7.

    Article  PubMed  Google Scholar 

  90. Dahl AA, Fosså SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, Kiserud CE. Employment status and work ability in long-term young adult cancer survivors. J Adolesc Young Adult Oncol. 2019;8(3):304–11.

    Article  PubMed  Google Scholar 

  91. Ketterl TG, Syrjala KL, Casillas J, Jacobs LA, Palmer SC, McCabe MS, Ganz PA, Overholser L, Partridge A, Rajotte EJ, Rosenberg AR, Risendal B, Rosenstein DL, Baker KS. Lasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors. Cancer. 2019;125(11):1908–17.

    Article  PubMed  Google Scholar 

  92. Lo AC, Samuel V, Chen B, Savage KJ, Freeman C, Goddard K. Evaluation of the discussion of late effects and screening recommendations in survivors of adolescent and young adult (AYA) lymphoma. J Cancer Surviv. 2021;15(2):179–89.

    Article  PubMed  Google Scholar 

  93. Rubinstein EB, Miller WL, Hudson SV, Howard J, O’Malley D, Tsui J, Lee HS, Bator A, Crabtree BF. Cancer survivorship care in advanced primary care practices: a qualitative study of challenges and opportunities. JAMA Intern Med. 2017;177(12):1726–32.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Shalom MM, Hahn EE, Casillas J, Ganz PA. Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract. 2011;7(5):314–8.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Taylor K, Monterosso L, Bulsara C. Qualitative results from a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care. Eur J Oncol Nurs. 2018;35:9–14.

    Article  PubMed  Google Scholar 

  96. Berg CJ, Vanderpool RC, Getachew B, Payne JB, Johnson MF, Sandridge Y, Bierhoff J, Le L, Johnson R, Weber A, Patterson A, Dorvil S, Mertens A. A hope-based intervention to address disrupted goal pursuits and quality of life among young adult cancer survivors. J Cancer Educ. 2020;35(6):1158–69.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Arrieta H, Astrugue C, Regueme S, Durrieu J, Maillard A, Rieger A, Terrebonne E, Laurent C, Maget B, Servent V, Lavau-Denès S, Dauba J, Fonck M, Thiébaut R, Bourdel-Marchasson I. Effects of a physical activity programme to prevent physical performance decline in onco-geriatric patients: a randomized multicentre trial. J Cachexia Sarcopenia Muscle. 2019;10(2):287–97.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Mayer DK, Gerstel A, Leak AN, Smith SK. Patient and provider preferences for survivorship care plans. J Oncol Pract. 2012;8(4):e80–6.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Franco K, Shuk E, Philip E, Blanch-Hartigan D, Parker PA, Matasar M, Horwitz S, Kissane D, Banerjee SC, Bylund CL. Communication between oncologists and lymphoma survivors during follow-up consultations: a qualitative analysis. J Psychosoc Oncol. 2017;35(5):513–30.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Viscuse P, Yost KJ, Jenkins S, Lackore K, Habermann T, Thanarajasingam G, Thompson C. Impact of lymphoma survivorship clinic visit on patient-centered outcomes. J Cancer Surviv. 2019;13(3):344–52.

    Article  PubMed  Google Scholar 

  101. Taylor K, Chivers P, Bulsara C, Joske D, Bulsara M, Monterosso L. Care After Lymphoma (CALy) trial: a phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care. Eur J Oncol Nurs. 2019;40:53–62.

    Article  PubMed  Google Scholar 

  102. van der Hout A, van Uden-Kraan CF, Holtmaat K, Jansen F, Lissenberg-Witte BI, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol. 2020;21(1):80–94.

    Article  PubMed  Google Scholar 

  103. van der Hout A, Holtmaat K, Jansen F, Lissenberg-Witte BI, van Uden-Kraan CF, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? Acta Oncol. 2021;60(4):403–11.

    Article  PubMed  Google Scholar 

  104. Blanch-Hartigan D, Forsythe LP, Alfano CM, Smith T, Nekhlyudov L, Ganz PA, Rowland JH. Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol. 2014;32(15):1578–85.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27(20):3338–45.

    Article  PubMed  Google Scholar 

  106. Hathiramani S, Pettengell R, Moir H, Younis A. Lymphoma survivors’ experience of participation in a home-based intervention post-chemotherapy. Qual Life Res. 2019;28(11):2951–5.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Lize N, Raijmakers N, van Lieshout R, Youssef-El Soud M, van Limpt A, van der Linden M, Beijer S. Psychosocial consequences of a reduced ability to eat for patients with cancer and their informal caregivers: a qualitative study. Eur J Oncol Nurs. 2020;49:101838.

    Article  PubMed  Google Scholar 

  108. Moinpour CM, Unger JM, Ganz PA, Kornblith AB, Gaynor ER, Bowers MA, Gatti GS, Kaminski MS, Erba HP, Wang T, Yoon J, Press OW, Fisher RI. Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin’s disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208. J Cancer Surviv. 2017;11(1):32–40.

    Article  PubMed  Google Scholar 

  109. Smith SK, Zimmerman S, Williams CS, Preisser JS, Clipp EC. Post-traumatic stress outcomes in non-Hodgkin’s lymphoma survivors. J Clin Oncol. 2008;26(6):934–41.

    Article  PubMed  Google Scholar 

  110. Pingali SR, Jewell SW, Havlat L, Bast MA, Thompson JR, Eastwood DC, Bartlett NL, Armitage JO, Wagner-Johnston ND, Vose JM, Fenske TS. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission. Cancer. 2014;120(14):2122–9.

    Article  PubMed  Google Scholar 

  111. Thompson CA, Ghesquieres H, Maurer MJ, Cerhan JR, Biron P, Ansell SM, Chassagne-Clément C, Inwards DJ, Gargi T, Johnston PB, Nicolas-Virelizier E, Macon WR, Peix M, Micallef IN, Sebban C, Nowakowski GS, Porrata LF, Weiner GJ, Witzig TE, Habermann TM, Link BK. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol. 2014;32(31):3506–12.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19(2):48–79.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Luctkar-Flude M, Aiken A, McColl MA, Tranmer J. A comprehensive framework and key guideline recommendations for the provision of evidence-based breast cancer survivorship care within the primary care setting. Fam Pract. 2015;32(2):129–40.

    Article  PubMed  Google Scholar 

  114. Eichenauer DA, Aleman BMP, André M, Federico M, Hutchings M, Illidge T, Engert A, Ladetto M, ESMO Guidelines Committee. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv19–29.

    Article  PubMed  CAS  Google Scholar 

  115. Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. (Version 5.0). 2018. http://www.survivorshipguidelines.org/pdf/2018/cog_ltfu_guidelines_v5.pdf. Accessed 10 August 2023.

  116. National Comprehensive Cancer Network. Breast screening guideline. [date unknown]. https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf. Accessed 10 August 2023.

  117. National Comprehensive Cancer Centre. Colorectal cancer screening guideline. https://www.nccn.org/patients/guidelines/content/PDF/colorectal-screening-patient.pdf. Accessed 10 August 2023.

  118. National Comprehensive Cancer Network. Lung screening guideline. [date unknown]. https://www.nccn.org/patients/guidelines/content/PDF/lung_screening-patient.pdf. Accessed 10 August 2023.

  119. Centre for Disease Control. Adult immunization schedule by age. 2023. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html#table-age. Accessed 10 August 2023.

  120. National Comprehensive Cancer Network. NCCN guidelines treatment by cancer type. 2023. https://www.nccn.org/guidelines/category_1. Accessed 10 August 2023.

  121. National Cancer Institute. Sleep problems in people with cancer. 2021. https://www.cancer.gov/about-cancer/treatment/side-effects/sleep-problems. Accessed 13 September 2022.

  122. American Society of Clinical Oncology. Screening and assessment-fatigue in cancer survivors. [date unknown]. https://old-prod.asco.org/sites/new-www.asco.org/files/content-files/practice-and-guidelines/documents/fatigue-algorithm.pdf. Accessed 13 September 2022.

  123. Armenian SH, Lacchetti C, Lenihan D. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline summary. J Oncol Pract. 2017;13(4):270–5.

    Article  PubMed  Google Scholar 

  124. Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F, ESMO Guidelines Working Group. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23 Suppl 7:vii155-66.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the contributions of Lourdes Calvente and Farheen Manji who were involved in developing the search strategy and protocol and aiding in synthesizing the findings from full-text articles.

Funding

Funding for this study was provided by the Princess Margaret Cancer Foundation- Lyon Share Fund.  This work has not been presented previously.

Author information

Authors and Affiliations

  1. Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada

    Melanie Powis, Saidah Hack & Vishal Kukreti

  2. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 700 University Ave, Suite 6-223, Toronto, ON, M5G 1X6, Canada

    Melanie Powis & Vishal Kukreti

  3. Library and Information Services, University Health Network, Toronto, ON, Canada

    Rouhi Fazelzad

  4. Department of Medicine, University of Toronto, Toronto, ON, Canada

    David Hodgson & Vishal Kukreti

  5. Radiation Medicine Program, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada

    David Hodgson

Authors
  1. Melanie Powis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saidah Hack
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rouhi Fazelzad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vishal Kukreti
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by MP, RF, SH, and VK. The first draft of the manuscript was written by MP, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Vishal Kukreti.

Ethics declarations

Ethics approval

Scoping literature review, ethics approval was not required.

Consent to participate

Not applicable.

Consent to publish

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 211 KB)

Supplementary file2 (DOCX 84 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Powis, M., Hack, S., Fazelzad, R. et al. Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a scoping review. J Cancer Surviv (2023). https://doi.org/10.1007/s11764-023-01500-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11764-023-01500-3

Keywords

Search

Navigation